1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
Incidence, Severity and Impact of Influenza Meeting
The "Incidence, Severity and Impact of Influenza Meeting" hosted discussions on the assessment of the impact of influenza epidemics, including infection incidence and severity, and the burden of mortality.
Are statins protective in patients with severe respiratory infections? Two new studies from EuropeArchived
In recent years there have been a series of arguments and findings suggesting that Statins (HMG-CoA reductase inhibitors) which used widely to lower cholesterol levels may also be important in reducing the risk associated with severe infective conditions.
Chronological overview of the 2009/2010 H1N1 influenza pandemic and the response of the Centre for Infectious Disease Control (RIVM)Archived
The Centre for Infectious Disease Control (CIb) of the Dutch National Institute for Public Health and the Environment (RIVM) has compiled a chronological overview of that country’s response to the 2009 influenza A(H1N1) pandemic.
Influenza A (H3N2)v Virus in Humans and Swine in the United States – an updateArchived
A report in the US Centers for Disease Control and Prevention (CDC) MMWR this week describes the investigation of mild respiratory illness among swine and people at a county fair in Indiana, USA between 8 and 14 July 2012. This is an important report as it is very clearly documents simultaneous detection of H3N2v influenza viruses in humans and swine in close contact.
Epidemiological update A(H7N9) influenza, 6 February 2014
In March 2013, Chinese authorities announced the identification of a novel reassortant A(H7N9) influenza virus in patients in eastern China. Since then, human cases have continued to be reported, and as of 7 February 2014 (Figure 1), there have been 308 laboratory-confirmed cases: Zhejiang (122), Guangdong (54), Shanghai (42), Jiangsu (36), Fujian (19), Hunan (7), Jiangxi (5), Henan (4), Anhui (4) ,Beijing (3), Shandong (2), Hebei (1), Guangxi (2), Guizhou (1), Hong Kong (4) and Taiwan (2). In addition, the virus has been detected in one asymptomatic case in Beijing.
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt, 9 April 2015
Epidemiological update: increase in reporting of human cases of A(H5N1) influenza, Egypt
Targeted testing for viral hepatitis: Europe’s persistent public health challenge
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.